Moreover, it is reported that EXT1 promoter hypermethylation was detected in many types of cancers, including non‐melanoma skin cancer and leukaemia, especially acute promyelocytic leukaemia and acute lymphoblastic leukaemia.21 This evidence concerns the gene EXT1 and acute lymphoblastic leukemia.